Please ensure Javascript is enabled for purposes of website accessibility
Inicio > Productos > Anticuerpos > Biosimilares

Anti-Human Coagulation Factor XI Reference Antibody (Abelacimab, RUO) (HY171026)

Anti-Human Coagulation Factor XI Reference Antibody (Abelacimab, RUO)
Anti-Human Coagulation Factor XI Reference Antibody (Abelacimab, RUO)
Anti-Human Coagulation Factor XI Reference Antibody (Abelacimab, RUO)
Anti-Human Coagulation Factor XI Reference Antibody (Abelacimab, RUO)
Anti-Human Coagulation Factor XI Reference Antibody (Abelacimab, RUO)
Anti-Human Coagulation Factor XI Reference Antibody (Abelacimab, RUO)
Precio(USD):
Especificación:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
Número:
Contáctenos
  • Vista general

  • Imágenes

  • Referencias

  • Datasheet

  • SDS

Vista general
Número de catálogoHY171026
Descripción
Abelacimab (HY171026) is a research-grade recombinant antibody targeting Plasma thromboplastin antecedent. Produced in mammalian cells with native-like glycosylation.
Highlights
  • ●Research Grade — For PK/PD studies, assay development, and ADA research.
  • ●Native Glycosylation — Mammalian expression ensures native-like patterns.
Reactividad de especiesHuman
AplicacionesELISA, Bioactivity: FACS, Functional assay, Research in vivo
Especie huéspedHuman
ClonalidadMonoclonal
IsotipoIgG1-lambda
Sistema de expresión Mammalian cells
Objetivo Plasma thromboplastin antecedent, PTA, Coagulation factor XI, F11, FXI
Nivel de endotoxinas < 10 EU/mg
Pureza >95% purity as determined by SDS-PAGE.
Purificación Protein A/G purified from cell culture supernatant.
Número de acceso P03951
Forma Liquid
Buffer de almacenamiento 0.01M PBS pH 7.4

Consulte la información específica del buffer en la copia impresa del datasheet o en el COA específico del lote.

Estabilidad y almacenamiento Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Nombres alternativosNVS250519, 2098724-83-3, FXI, FXIa,
Fondo

Coagulation factor XI (F11) is a ~70 kDa protein. Factor XI triggers the middle phase of the intrinsic pathway of blood coagulation by activating factor IX.

Nota For research use only. Not suitable for clinical or therapeutic use.
Isotype Control Human IgG1, lambda Isotype Control antibody (HyHEL-10) (HP248107)
Imágenes
  • Anti-Human Coagulation Factor XI Reference Antibody (Abelacimab, RUO)

    SEC-HPLC

    SEC-HPLC detection for Research Grade Abelacimab.

  • Anti-Human Coagulation Factor XI Reference Antibody (Abelacimab, RUO)

    Bioactivity

    Detects F11 in indirect ELISAs.

  • Anti-Human Coagulation Factor XI Reference Antibody (Abelacimab, RUO)

    SDS-PAGE

    SDS-PAGE for Research Grade Abelacimab.

Referencias
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recomendación

Contáctenos para cotizaciones personalizadas, solicitudes en masa y cualquier otro problema.

Correo: [email protected]

Lista de distribuidores